124 related articles for article (PubMed ID: 8973864)
1. Randomized trial of two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status.
Lander FA; Ritchie DM
Clin Oncol (R Coll Radiol); 1996; 8(6):408. PubMed ID: 8973864
[No Abstract] [Full Text] [Related]
2. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.
Macbeth FR; Bolger JJ; Hopwood P; Bleehen NM; Cartmell J; Girling DJ; Machin D; Stephens RJ; Bailey AJ
Clin Oncol (R Coll Radiol); 1996; 8(3):167-75. PubMed ID: 8814371
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for inoperable lung cancer.
Timothy AR; Girling DJ; Saunders MI; Macbeth F; Hoskin PJ;
Clin Oncol (R Coll Radiol); 2001; 13(2):86-7. PubMed ID: 11373884
[No Abstract] [Full Text] [Related]
4. [A controlled study of postoperative radiotherapy for patients with completely resected non small cell lung carcinoma].
Saintigny P; Noël G; Mazeron JJ
Cancer Radiother; 2000; 4(4):318-9. PubMed ID: 10994397
[No Abstract] [Full Text] [Related]
5. Continuous hyperfractionated accelerated therapy in non-small-cell lung cancer.
Würschmidt F; Heilmann HP
Lancet; 1997 Sep; 350(9081):888. PubMed ID: 9310628
[No Abstract] [Full Text] [Related]
6. Palliative radiotherapy regimens for non-small cell lung cancer.
Lester JF; Macbeth FR; Toy E; Coles B
Cochrane Database Syst Rev; 2006 Oct; (4):CD002143. PubMed ID: 17054152
[TBL] [Abstract][Full Text] [Related]
7. [Inoperable bronchial cancer. 1. Effect of histological tumor type on survival following intensive radiotherapy].
Oehler W; Lessel A; Hüttner J
Radiobiol Radiother (Berl); 1987; 28(6):743-8. PubMed ID: 2832872
[No Abstract] [Full Text] [Related]
8. Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working Party.
Macbeth FR; Wheldon TE; Girling DJ; Stephens RJ; Machin D; Bleehen NM; Lamont A; Radstone DJ; Reed NS
Clin Oncol (R Coll Radiol); 1996; 8(3):176-81. PubMed ID: 8814372
[TBL] [Abstract][Full Text] [Related]
9. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party.
Br J Cancer; 1992 Jun; 65(6):934-41. PubMed ID: 1377484
[TBL] [Abstract][Full Text] [Related]
10. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
11. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
Rowell NP; Williams CJ
Cochrane Database Syst Rev; 2001; (1):CD002935. PubMed ID: 11279780
[TBL] [Abstract][Full Text] [Related]
12. A systematic overview of radiation therapy effects in non-small cell lung cancer.
Sirzén F; Kjellén E; Sörenson S; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):493-515. PubMed ID: 14596509
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.
Nguyen LN; Komaki R; Allen P; Schea RA; Milas L
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1053-6. PubMed ID: 10421538
[TBL] [Abstract][Full Text] [Related]
14. Contemporary brachytherapy approaches in non-small-cell lung cancer.
Hilaris BS; Mastoras DA
J Surg Oncol; 1998 Dec; 69(4):258-64. PubMed ID: 9881944
[TBL] [Abstract][Full Text] [Related]
15. Aggressive treatment for the fit elderly with non-small-cell lung cancer? Yes!
Sequist LV; Lynch TJ
J Clin Oncol; 2003 Sep; 21(17):3186-8. PubMed ID: 12874267
[No Abstract] [Full Text] [Related]
16. Are the results of RTOG 0617 mysterious?
Cox JD
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1042-4. PubMed ID: 22284026
[No Abstract] [Full Text] [Related]
17. A case of radiation myelopathy after 2 x 8.5 Gy for inoperable non-small cell lung cancer.
Dardoufas C; Plataniotis GA; Damatopoulou A; Kouvaris J; Vlahos L
Eur J Cancer; 1995 Dec; 31A(13-14):2418-9. PubMed ID: 8652283
[No Abstract] [Full Text] [Related]
18. Timing of radiotherapy in asymptomatic patients with inoperable non-small cell lung cancer: a survival analysis and literature review.
Ampil FL; Sanghani SV
Radiat Med; 1996; 14(4):211-4. PubMed ID: 8916266
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer.
Vansteenkiste J; Betticher D; Eberhardt W; De Leyn P
J Thorac Oncol; 2007 Aug; 2(8):684-5. PubMed ID: 17762333
[No Abstract] [Full Text] [Related]
20. Short-course palliative radiotherapy in non-small-cell lung cancer: results of a prospective study.
Lupattelli M; Maranzano E; Bellavita R; Chionne F; Darwish S; Piro F; Latini P
Am J Clin Oncol; 2000 Feb; 23(1):89-93. PubMed ID: 10683087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
